Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Red blood cells (RBCs) release extracellular vesicles (EVs) including both endosome-derived exosomes and plasma-membrane-derived microvesicles (MVs). RBC-derived EVs (RBCEVs) are secreted during erythropoiesis, physiological cellular aging, disease conditions, and in response to environmental stressors. RBCEVs are enriched in various bioactive molecules that facilitate cell to cell communication and can act as markers of disease. RBCEVs contribute towards physiological adaptive responses to hypoxia as well as pathophysiological progression of diabetes and genetic non-malignant hematologic disease. Moreover, a considerable number of studies focus on the role of EVs from stored RBCs and have evaluated post transfusion consequences associated with their exposure. Interestingly, RBCEVs are important contributors toward coagulopathy in hematological disorders, thus representing a unique evolving area of study that can provide insights into molecular mechanisms that contribute toward dysregulated hemostasis associated with several disease conditions. Relevant work to this point provides a foundation on which to build further studies focused on unraveling the potential roles of RBCEVs in health and disease. In this review, we provide an analysis and summary of RBCEVs biogenesis, composition, and their biological function with a special emphasis on RBCEV pathophysiological contribution to coagulopathy. Further, we consider potential therapeutic applications of RBCEVs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 2×
“Despite their heterogeneity, EVs overlap in size, density, and content, which poses a significant technical challenge for separation and characterization of distinct EV subpopulations [10].”
BackgroundShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“Exosomes are generated along the endosomal pathway after the first step of plasma membrane (PM) invagination to form early endosomes [11].”
BackgroundBiological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431 · cited 1×
“However, appearance of anti-PEG immune response upon repeated administrations resulted in lowered drug efficacy, shifting the focus towards biomimetic particles that mimic self and therefore do not trigger an immune response [193].”
BackgroundJohnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931 · cited 3×
“Exosome release and uptake is a constitutive homeostatic process among many cell types except mature RBCs which lack the endocytic machinery [4,18].”
BackgroundMethodExosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639 · cited 1×
“Delivery of miRNA or siRNA payload using EVs has focused on anti-cancer treatments in rodent models of glioma [182], carcinoma [183], and pancreatic cancer [184,185].”
BackgroundBiodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Regulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Syndecan–syntenin–ALIX regulates the biogenesis of exosomes
Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2502 · Cited by 1,899
Research works printed but not linked: 216
- Horder, 1899, Blood dust or blood granules: A new constituent of the blood?, Lancet, 154, 1015, 10.1016/S0140-6736(01)59201-6 · doi:10.1016/s0140-6736(01)59201-6
- Nguyen, D.B., Ly, T.B.T., and Bernhardt, I. (2017). Microvesicles Released from Human Red Blood Cells: Properties and Potential Applications, IntechOpen. · DOI
- Szatanek, R., Baj-Krzyworzeka, M., Zimoch, J., Lekka, M., Siedlar, M., and Baran, J. (2017). The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int. J. Mol. Sci., 18. · DOI · Paper page
- Pan, 1983, Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor, Cell, 33, 967, 10.1016/0092-8674(83)90040-5 · DOI · Paper page
- Buschow, 2009, MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways, Traffic, 10, 1528, 10.1111/j.1600-0854.2009.00963.x · DOI · Paper page
- Theos, 2006, A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis, Dev. Cell, 10, 343, 10.1016/j.devcel.2006.01.012 · DOI · Paper page
- Baixauli, 2016, ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins, Nat. Commun., 7, 13588, 10.1038/ncomms13588 · DOI · Paper page
- Guix, 2017, Tetraspanin 6: A pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments, Mol. Neurodegener., 12, 25, 10.1186/s13024-017-0165-0 · DOI · Paper page
- Tamai, 2010, Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein, Biochem. Biophys. Res. Commun., 399, 384, 10.1016/j.bbrc.2010.07.083 · DOI · Paper page
- Blanc, 2009, The water channel aquaporin-1 partitions into exosomes during reticulocyte maturation: Implication for the regulation of cell volume, Blood, 114, 3928, 10.1182/blood-2009-06-230086 · DOI · Paper page
- Wolf, 1967, The nature and significance of platelet products in human plasma, Br. J. Haematol., 13, 269, 10.1111/j.1365-2141.1967.tb08741.x · DOI · Paper page
- Hristov, 2004, Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro, Blood, 104, 2761, 10.1182/blood-2003-10-3614 · DOI · Paper page
- Hurley, 2010, Membrane budding and scission by the ESCRT machinery: It’s all in the neck, Nat. Rev. Mol. Cell Biol., 11, 556, 10.1038/nrm2937 · DOI · Paper page
- Penalva, M. (2002). Faculty Opinions recommendation of Escrt-III: An endosome-associated heterooligomeric protein complex required for mvb sorting. Fac. Opin. Post Publ. Peer Rev. Biomed. Lit. · doi:10.3410/f.1009409.126008
- Babst, 2002, Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body, Dev. Cell, 3, 283, 10.1016/S1534-5807(02)00219-8 · DOI · Paper page
- Bilodeau, 2003, Vps27-Hse1 and ESCRT-I complexes cooperate to increase efficiency of sorting ubiquitinated proteins at the endosome, J. Cell Biol., 163, 237, 10.1083/jcb.200305007 · DOI · Paper page
- Katzmann, 2001, Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I, Cell, 106, 145, 10.1016/S0092-8674(01)00434-2 · DOI · Paper page
- Katzmann, 2003, Vps27 recruits ESCRT machinery to endosomes during MVB sorting, J. Cell Biol., 162, 413, 10.1083/jcb.200302136 · DOI · Paper page
- Stuffers, 2009, Multivesicular endosome biogenesis in the absence of ESCRTs, Traffic, 10, 925, 10.1111/j.1600-0854.2009.00920.x · DOI · Paper page
- Charrin, 2011, The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis, Dev. Cell, 21, 708, 10.1016/j.devcel.2011.08.019 · DOI · Paper page
- Trajkovic, 2008, Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, 319, 1244, 10.1126/science.1153124 · DOI · Paper page
- Jorge, 2013, The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes, J. Biol. Chem., 288, 11649, 10.1074/jbc.M112.445304 · DOI · Paper page
- Kajimoto, 2013, Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes, Nat. Commun., 4, 2712, 10.1038/ncomms3712 · DOI · Paper page
- Bergam, 2015, Apolipoprotein E Regulates Amyloid Formation within Endosomes of Pigment Cells, Cell Rep., 13, 43, 10.1016/j.celrep.2015.08.057 · DOI · Paper page
- Gauthier, 2017, Enhanced exosome secretion in Down syndrome brain—A protective mechanism to alleviate neuronal endosomal abnormalities, Acta Neuropathol. Commun., 5, 65, 10.1186/s40478-017-0466-0 · DOI · Paper page
- Odintsova, 2013, Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor, J. Biol. Chem., 288, 26323, 10.1074/jbc.M112.439380 · DOI · Paper page
- Vidal, 1997, Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation, J. Cell Sci., 110, 1867, 10.1242/jcs.110.16.1867 · DOI · Paper page
- Blanc, 2005, Exosome release by reticulocytes—An integral part of the red blood cell differentiation system, Blood Cells Mol. Dis., 35, 21, 10.1016/j.bcmd.2005.04.008 · DOI
- Ney, 2011, Normal and disordered reticulocyte maturation, Curr. Opin. Hematol., 18, 152, 10.1097/MOH.0b013e328345213e · DOI · Paper page
- 2018, Proteomics study of human cord blood reticulocyte-derived exosomes, Sci. Rep., 8, 14046, 10.1038/s41598-018-32386-2 · DOI
- Carayon, 2011, Proteolipidic composition of exosomes changes during reticulocyte maturation, J. Biol. Chem., 286, 34426, 10.1074/jbc.M111.257444 · DOI · Paper page
- Bryk, 2017, Quantitative Analysis of Human Red Blood Cell Proteome, J. Prot. Res., 16, 2752, 10.1021/acs.jproteome.7b00025 · DOI · Paper page
- Leal, 2018, Red Blood Cell Homeostasis: Mechanisms and Effects of Microvesicle Generation in Health and Disease, Front. Physiol., 9, 703, 10.3389/fphys.2018.00703 · DOI
- Willekens, 2003, Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation, Blood, 101, 747, 10.1182/blood-2002-02-0500 · DOI
- Willekens, 1997, Quantification of loss of haemoglobin components from the circulating red blood cell in vivo, Eur. J. Haematol., 58, 246, 10.1111/j.1600-0609.1997.tb01662.x · DOI · Paper page
- Willekens, 2008, Erythrocyte vesiculation: A self-protective mechanism?, Br. J. Haematol., 141, 549, 10.1111/j.1365-2141.2008.07055.x · DOI · Paper page
- Bosman, 2012, The proteome of erythrocyte-derived microparticles from plasma: New clues for erythrocyte aging and vesiculation, J. Prot., 76, 203, 10.1016/j.jprot.2012.05.031 · DOI
- Lux, 2016, Anatomy of the red cell membrane skeleton: Unanswered questions, Blood, 127, 187, 10.1182/blood-2014-12-512772 · DOI · Paper page
- Ursitti, 1993, Ultrastructure and immunocytochemistry of the isolated human erythrocyte membrane skeleton, Cell Motil. Cytoskeleton, 25, 30, 10.1002/cm.970250105 · doi:10.1002/cm.970250105
- Liu, 1984, Oligomeric states of spectrin in normal erythrocyte membranes: Biochemical and electron microscopic studies, Cell, 37, 587, 10.1016/0092-8674(84)90389-1 · DOI
- Salomao, 2006, Mammalian alpha I-spectrin is a neofunctionalized polypeptide adapted to small highly deformable erythrocytes, Proc. Natl. Acad. Sci. USA, 103, 643, 10.1073/pnas.0507661103 · doi:10.1073/pnas.0507661103
- Picart, 2000, Actin protofilament orientation in deformation of the erythrocyte membrane skeleton, Biophys. J., 79, 2987, 10.1016/S0006-3495(00)76535-0 · DOI
- An, 2007, Tropomyosin modulates erythrocyte membrane stability, Blood, 109, 1284, 10.1182/blood-2006-07-036954 · DOI
- Moyer, 2010, Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton, Blood, 116, 2590, 10.1182/blood-2010-02-268458 · DOI · Paper page
- Li, 1998, Adducin Preferentially Recruits Spectrin to the Fast Growing Ends of Actin Filaments in a Complex Requiring the MARCKS-related Domain and a Newly Defined Oligomerization Domain, J. Biol. Chem., 273, 19329, 10.1074/jbc.273.30.19329 · DOI
- Khan, 2008, Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1, J. Biol. Chem., 283, 14600, 10.1074/jbc.M707818200 · DOI
- Han, 2000, Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization, Nat. Struct. Biol., 7, 871, 10.1038/82819 · DOI
- Manno, 2005, Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation, J. Biol. Chem., 280, 7581, 10.1074/jbc.M410650200 · doi:10.1074/jbc.m410650200
- Low, 1991, Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability, Blood, 77, 1581, 10.1182/blood.V77.7.1581.1581 · DOI
- Westerman, 2008, Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy, Br. J. Haematol., 142, 126, 10.1111/j.1365-2141.2008.07155.x · DOI · Paper page
- Ferru, 2014, Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase, Haematologica, 99, 570, 10.3324/haematol.2013.084533 · DOI
- Daleke, 2008, Regulation of phospholipid asymmetry in the erythrocyte membrane, Curr. Opin. Hematol., 15, 191, 10.1097/MOH.0b013e3282f97af7 · DOI · Paper page
- Said, 2017, Physiologic Impact of Circulating RBC Microparticles upon Blood-Vascular Interactions, Front. Physiol., 8, 1120, 10.3389/fphys.2017.01120 · DOI
- Gonzalez, 2009, The influence of membrane physical properties on microvesicle release in human erythrocytes, PMC Biophys., 2, 7, 10.1186/1757-5036-2-7 · DOI
- Nguyen, 2016, Characterization of Microvesicles Released from Human Red Blood Cells, Cell. Physiol. Biochem., 38, 1085, 10.1159/000443059 · DOI
- Wesseling, 2016, Novel Insights in the Regulation of Phosphatidylserine Exposure in Human Red Blood Cells, Cell. Physiol. Biochem., 39, 1941, 10.1159/000447891 · doi:10.1159/000447891
- Lang, 2008, Eryptosis, a window to systemic disease, Cell. Physiol. Biochem., 22, 373, 10.1159/000185448 · DOI · Paper page
- Salzer, 2002, Ca++-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin, Blood, 99, 2569, 10.1182/blood.V99.7.2569 · DOI · Paper page
- Wesseling, 2016, Phosphatidylserine Exposure in Human Red Blood Cells Depending on Cell Age, Cell. Physiol. Biochem., 38, 1376, 10.1159/000443081 · DOI
- Sudnitsyna, J., Skverchinskaya, E., Dobrylko, I., Nikitina, E., Gambaryan, S., and Mindukshev, I. (2020). Microvesicle Formation Induced by Oxidative Stress in Human Erythrocytes. Antioxidants, 9. · doi:10.20944/preprints202008.0717.v1
- Stowell, 2013, Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization, Transfusion, 53, 2248, 10.1111/trf.12106 · DOI
- Kuo, 2012, ARRDC1 as a mediator of microvesicle budding, Proc. Natl. Acad. Sci. USA, 109, 4025, 10.1073/pnas.1201441109 · DOI
- Xu, B., Fu, Y., Liu, Y., Agvanian, S., Wirka, R.C., Baum, R., Zhou, K., Shaw, R.M., and Hong, T. (2017). The ESCRT-III pathway facilitates cardiomyocyte release of cBIN1-containing microparticles. PLoS Biol., 15. · DOI · Paper page
- Li, 2012, RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells, Oncogene, 31, 4740, 10.1038/onc.2011.636 · DOI · Paper page
- Wilson, 2013, Rho GTPases and their roles in cancer metabolism, Trends Mol. Med., 19, 74, 10.1016/j.molmed.2012.10.011 · DOI · Paper page
- Shrimpton, 2005, Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation, Blood, 106, 1604, 10.1182/blood-2004-03-1095 · DOI · Paper page
- Kim, 2015, EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research, Semin. Cell Dev. Biol., 40, 4, 10.1016/j.semcdb.2015.02.005 · DOI
- Kim, D.-K., Kang, B., Kim, O.Y., Choi, D.-S., Lee, J., Kim, S.R., Go, G., Yoon, Y.J., Kim, J.H., and Jang, S.C. (2013). EVpedia: An integrated database of high-throughput data for systemic analyses of extracellular vesicles. J. Extracell. Vesicles, 2. · DOI · Paper page
- Keerthikumar, 2016, ExoCarta: A Web-Based Compendium of Exosomal Cargo, J. Mol. Biol., 428, 688, 10.1016/j.jmb.2015.09.019 · DOI · Paper page
- Prudent, 2018, Proteomics of Stored Red Blood Cell Membrane and Storage-Induced Microvesicles Reveals the Association of Flotillin-2 With Band 3 Complexes, Front. Physiol., 9, 421, 10.3389/fphys.2018.00421 · DOI
- Rubin, 2008, Microparticles in stored red blood cells: An approach using flow cytometry and proteomic tools, Vox Sang., 95, 288, 10.1111/j.1423-0410.2008.01101.x · DOI · Paper page
- Antonelou, 2016, Update on extracellular vesicles inside red blood cell storage units: Adjust the sails closer to the new wind, Transfus. Apher. Sci., 55, 92, 10.1016/j.transci.2016.07.016 · DOI
- Tissot, 2013, Blood microvesicles: From proteomics to physiology, Transl. Prot., 1, 38
- Hamilton, 2010, MicroRNA in erythrocytes, Biochem. Soc. Trans., 38, 229, 10.1042/BST0380229 · DOI · Paper page
- Aalto, 2012, Small non-coding RNAs mount a silent revolution in gene expression, Curr. Opin. Cell Biol., 24, 333, 10.1016/j.ceb.2012.03.006 · DOI
- Alder, 2012, miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing, J. Neuroimmunol., 248, 32, 10.1016/j.jneuroim.2011.10.006 · DOI · Paper page
- Karius, 2012, MicroRNAs in cancer management and their modulation by dietary agents, Biochem. Pharmacol., 83, 1591, 10.1016/j.bcp.2012.02.004 · DOI
- Saki, 2015, Involvement of MicroRNA in T-Cell Differentiation and Malignancy, Int. J. Hematol. Oncol. Stem Cell Res., 9, 33
- Huang, 2019, MicroRNA Profiling of Exosomes Derived from Red Blood Cell Units: Implications in Transfusion-Related Immunomodulation, Biomed Res. Int., 2019, 2045915, 10.1155/2019/2045915 · DOI · Paper page
- Rasheed, 2019, Author Correction: MicroRNA-125b-5p regulates IL-1β induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-κB signaling in human osteoarthritic chondrocytes, Sci. Rep., 9, 14729, 10.1038/s41598-019-50844-3 · doi:10.1038/s41598-019-50844-3
- Diao, 2017, MicroRNA-125b-5p modulates the inflammatory state of macrophages via targeting B7-H4, Biochem. Biophys. Res. Commun., 491, 912, 10.1016/j.bbrc.2017.07.135 · DOI
- Yang, 2016, MicroRNA-125b-5p mimic inhibits acute liver failure, Nat. Commun., 7, 11916, 10.1038/ncomms11916 · DOI
- Morelli, 2015, Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo, Leukemia, 29, 2173, 10.1038/leu.2015.124 · DOI
- Doss, J.F., Corcoran, D.L., Jima, D.D., Telen, M.J., Dave, S.S., and Chi, J.-T. (2015). A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes. BMC Genomics, 16. · DOI · Paper page
- Sun, 2018, Different Erythrocyte MicroRNA Profiles in Low- and High-Altitude Individuals, Front. Physiol., 9, 1099, 10.3389/fphys.2018.01099 · DOI · Paper page
- Hua, Z., Lv, Q., Ye, W., Wong, C.-K.A., Cai, G., Gu, D., Ji, Y., Zhao, C., Wang, J., and Yang, B.B. (2006). MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE, 1. · DOI · Paper page
- Piriyapongsa, 2011, Transcription factor binding sites are highly enriched within microRNA precursor sequences, Biol. Direct, 6, 61, 10.1186/1745-6150-6-61 · DOI
- Hebert, 2007, High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma, Mol. Cancer, 6, 5, 10.1186/1476-4598-6-5 · DOI · Paper page
- Juzenas, 2017, A comprehensive, cell specific microRNA catalogue of human peripheral blood, Nucleic Acids Res., 45, 9290, 10.1093/nar/gkx706 · DOI · Paper page
- Doherty, 1998, Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin, Nat. Biotechnol., 16, 672, 10.1038/nbt0798-672 · DOI · Paper page
- Donadee, 2011, Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion, Circulation, 124, 465, 10.1161/CIRCULATIONAHA.110.008698 · DOI · Paper page
- Liu, 2013, Nitric oxide scavenging by red cell microparticles, Free Radic. Biol. Med., 65, 1164, 10.1016/j.freeradbiomed.2013.09.002 · DOI
- Herring, 2013, Microparticles in health and disease, J. Vet. Intern. Med., 27, 1020, 10.1111/jvim.12128 · DOI
- Poisson, 2020, Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm, J. Clin. Investig., 130, 2630, 10.1172/JCI124566 · DOI
- Harisa, 2017, Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles, Saudi Pharm. J., 25, 8, 10.1016/j.jsps.2015.06.010 · DOI
- Kuhn, 2017, Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia, Antioxid. Redox Signal., 26, 718, 10.1089/ars.2016.6954 · DOI · Paper page
- Jank, 2011, Vesicles Generated during Storage of Red Blood Cells Enhance the Generation of Radical Oxygen Speciesin Activated Neutrophils, Sci. World J., 11, 173, 10.1100/tsw.2011.25 · DOI
- Danesh, 2014, Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro, Blood, 123, 687, 10.1182/blood-2013-10-530469 · DOI · Paper page
- Hezel, M.E.V., Nieuwland, R., Bruggen, R.V., and Juffermans, N.P. (2017). The Ability of Extracellular Vesicles to Induce a Pro-Inflammatory Host Response. Int. J. Mol. Sci., 18. · DOI
- Almizraq, 2016, Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing, Transf. Apher. Sci., 55, 281, 10.1016/j.transci.2016.10.018 · DOI
- Wannez, 2019, Extracellular Vesicles in Red Blood Cell Concentrates: An Overview, Transf. Med. Rev., 33, 125, 10.1016/j.tmrv.2019.02.002 · DOI
- Sadallah, 2011, Ectosomes as modulators of inflammation and immunity, Clin. Exp. Immunol., 163, 26, 10.1111/j.1365-2249.2010.04271.x · DOI · Paper page
- Straat, 2016, Monocyte-mediated activation of endothelial cells occurs only after binding to extracellular vesicles from red blood cell products, a process mediated by β-integrin, Transfusion, 56, 3012, 10.1111/trf.13851 · doi:10.1111/trf.13851
- Fischer, 2017, Microparticles from stored red blood cells enhance procoagulant and proinflammatory activity, Transfusion, 57, 2701, 10.1111/trf.14268 · doi:10.1111/trf.14268
- Sadallah, 2008, Erythrocyte-derived ectosomes have immunosuppressive properties, J. Leukoc. Biol., 84, 1316, 10.1189/jlb.0108013 · DOI
- Nazimek, 2019, Syngeneic red blood cell–induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice, Clin. Exp. Allergy, 49, 1487, 10.1111/cea.13475 · DOI
- Bradlow, 1961, Liberation of material with platelet-like coagulant properties from intact red cells and particularly from reticulocytes, Br. J. Haematol., 7, 476, 10.1111/j.1365-2141.1961.tb00357.x · doi:10.1111/j.1365-2141.1961.tb00357.x
- Horne, 2006, The effect of red blood cells on thrombin generation, Br. J. Haematol., 133, 403, 10.1111/j.1365-2141.2006.06047.x · doi:10.1111/j.1365-2141.2006.06047.x
- Diamant, 2004, Cellular microparticles: New players in the field of vascular disease?, Eur. J. Clin. Investig., 34, 392, 10.1111/j.1365-2362.2004.01355.x · DOI · Paper page
- Spronk, 2012, Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa, J. Thromb. Haemost., 10, 1355, 10.1111/j.1538-7836.2012.04758.x · DOI · Paper page
- Koshiar, R.L., Somajo, S., Norstrom, E., and Dahlback, B. (2014). Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. PLoS ONE, 9. · doi:10.1371/journal.pone.0104200
- Levin, 2016, Impact of microparticles derived from erythrocytes on fibrinolysis, J. Thromb Thrombolysis, 41, 452, 10.1007/s11239-015-1299-y · doi:10.1007/s11239-015-1299-y
- Amirizadeh, 2019, Procoagulant Activity of Red Blood Cell-Derived Microvesicles during Red Cell Storage, Transfus. Med. Hemother., 46, 224, 10.1159/000494367 · doi:10.1159/000494367
- Tzounakas, 2016, Donor variation effect on red blood cell storage lesion: A multivariable, yet consistent, story, Transfusion, 56, 1274, 10.1111/trf.13582 · DOI
- Sweeney, 2009, Stored red blood cell supernatant facilitates thrombin generation, Transfusion, 49, 1569, 10.1111/j.1537-2995.2009.02196.x · DOI
- Rubin, 2013, Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation, Transfusion, 53, 1744, 10.1111/trf.12008 · DOI
- Camus, 2015, Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease, Blood, 125, 3805, 10.1182/blood-2014-07-589283 · DOI · Paper page
- Freedman, 2003, Nitric oxide and its relationship to thrombotic disorders: Nitric oxide and thrombotic disorders, J. Thromb. Haemost., 1, 1183, 10.1046/j.1538-7836.2003.00180.x · DOI
- Devalet, B., Mullier, F., Chatelain, B., Dogné, J.-M., and Chatelain, C. (2014). The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: A review. J. Extracell Vesicles, 3, (1). · DOI
- Yoshida, 2019, Red blood cell storage lesion: Causes and potential clinical consequences, Blood Transfus., 17, 27
- Macey, 2011, Flow cytometric analysis of microparticle phenotype and their role in thrombin generation, Cytometry B Clin. Cytom., 80, 57, 10.1002/cyto.b.20551 · doi:10.1002/cyto.b.20551
- Berckmans, 2001, Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation, Thromb. Haemost., 85, 639, 10.1055/s-0037-1615646 · DOI · Paper page
- Zubairova, 2015, Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots, Sci. Rep., 5, 17611, 10.1038/srep17611 · DOI
- Aharon, 2014, Extracellular vesicles in hematological disorders, Rambam Maimonides Med. J., 5, e0032, 10.5041/RMMJ.10166 · DOI
- Ataga, 2009, Hypercoagulability and thrombotic complications in hemolytic anemias, Haematologica, 94, 1481, 10.3324/haematol.2009.013672 · DOI · Paper page
- Allan, 1982, Release of spectrin-free spicules on reoxygenation of sickled erythrocytes, Nature, 295, 612, 10.1038/295612a0 · DOI
- Shet, 2003, Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes, Blood, 102, 2678, 10.1182/blood-2003-03-0693 · DOI · Paper page
- Schaap, 2009, Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease, Haematologica, 94, 1513, 10.3324/haematol.2009.008938 · DOI · Paper page
- Gerotziafas, 2012, The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles, Thromb. Haemost., 107, 1044, 10.1160/TH11-10-0689 · DOI
- Mahfoudhi, 2012, Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles, Br. J. Haematol., 156, 545, 10.1111/j.1365-2141.2011.08897.x · doi:10.1111/j.1365-2141.2011.08897.x
- Tantawy, 2013, Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications, Platelets, 24, 605, 10.3109/09537104.2012.749397 · DOI
- Nebor, D., Bowers, A., Connes, P., Hardy-Dessources, M.-D., Knight-Madden, J., Cumming, V., Reid, M., and Romana, M. (2014). Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia. PLoS ONE, 9. · DOI
- Kasar, 2014, Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease, J. Thromb. Thrombolysis, 38, 167, 10.1007/s11239-013-1028-3 · DOI
- Piccin, 2015, Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia, J. Extracell Vesicles, 4, 28414, 10.3402/jev.v4.28414 · DOI
- Hierso, 2017, Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: A prospective study, Br. J. Haematol., 176, 805, 10.1111/bjh.14476 · DOI
- Romana, 2013, Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children, Haematologica, 98, 862, 10.3324/haematol.2012.073619 · DOI
- Garnier, Y., Ferdinand, S., Etienne-Julan, M., Elana, G., Petras, M., Doumdo, L., Tressières, B., Lalanne-Mistrih, M.-L., Hardy-Dessources, M.-D., and Connes, P. (2017). Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients. PLoS ONE, 12. · DOI
- Romana, 2018, Microparticles in sickle cell disease, Clin. Hemorheol. Microcirc., 68, 319, 10.3233/CH-189014 · DOI
- Taher, 2008, Thalassemia and hypercoagulability, Blood Rev., 22, 283, 10.1016/j.blre.2008.04.001 · DOI · Paper page
- Musallam, 2011, Thrombosis in thalassemia: Why are we so concerned?, Hemoglobin, 35, 503, 10.3109/03630269.2011.605499 · DOI
- Pattanapanyasat, 2007, Activated platelet-derived microparticles in thalassaemia, Br. J. Haematol., 136, 462, 10.1111/j.1365-2141.2006.06449.x · DOI
- Pattanapanyasat, 2004, Flow cytometric quantitation of red blood cell vesicles in thalassemia, Cytometry B Clin. Cytom., 57, 23, 10.1002/cyto.b.10064 · DOI
- Habib, 2008, Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia, Haematologica, 93, 941, 10.3324/haematol.12460 · doi:10.3324/haematol.12460
- Chaichompoo, 2012, Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients, J. Proteomics, 76, 239, 10.1016/j.jprot.2012.06.004 · DOI
- Agouti, 2015, Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients, Br. J. Haematol., 171, 615, 10.1111/bjh.13609 · DOI
- Tantawy, 2013, Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: Relation to pulmonary hypertension and aortic wall stiffness, Eur. J. Haematol., 90, 508, 10.1111/ejh.12108 · DOI
- Kheansaard, 2018, Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction, Sci. Rep., 8, 13033, 10.1038/s41598-018-31386-6 · DOI
- Tripodi, 2009, Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma, Haematologica, 94, 1520, 10.3324/haematol.2009.010546 · DOI
- Macrae, 2018, The prothrombotic state in paroxysmal nocturnal hemoglobinuria: A multifaceted source, Haematologica, 103, 9, 10.3324/haematol.2017.177618 · DOI
- Hill, 2013, Thrombosis in paroxysmal nocturnal hemoglobinuria, Blood, 121, 4985, 10.1182/blood-2012-09-311381 · DOI · Paper page
- Kozuma, 2011, Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria, Br. J. Haematol., 152, 631, 10.1111/j.1365-2141.2010.08505.x · doi:10.1111/j.1365-2141.2010.08505.x
- Hugel, 1999, Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia, Blood, 93, 3451, 10.1182/blood.V93.10.3451.410k27_3451_3456 · DOI · Paper page
- Simak, 2004, Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria, Br. J. Haematol., 125, 804, 10.1111/j.1365-2141.2004.04974.x · DOI
- Ovchynnikova, 2018, The Shape Shifting Story of Reticulocyte Maturation, Front. Physiol., 9, 829, 10.3389/fphys.2018.00829 · DOI
- Mankelow, 2015, Autophagic vesicles on mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease, Blood, 126, 1831, 10.1182/blood-2015-04-637702 · DOI
- Kalluri, 2016, The biology and function of exosomes in cancer, J. Clin. Investig., 126, 1208, 10.1172/JCI81135 · DOI · Paper page
- Fitts, 2019, Exploiting Exosomes in Cancer Liquid Biopsies and Drug Delivery, Adv. Healthc. Mater., 8, e1801268, 10.1002/adhm.201801268 · DOI · Paper page
- Zhang, 2017, Characteristics and Roles of Exosomes in Cardiovascular Disease, DNA Cell Biol., 36, 202, 10.1089/dna.2016.3496 · DOI
- Jansen, 2017, Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases, Exosomes Cardiovasc. Dis., 998, 61, 10.1007/978-981-10-4397-0_4 · DOI
- Kanninen, 2016, Exosomes as new diagnostic tools in CNS diseases, Biochim. Biophys. Acta (BBA) Mol. Basis Dis., 1862, 403, 10.1016/j.bbadis.2015.09.020 · DOI · Paper page
- Alipoor, 2016, Exosomes and Exosomal miRNA in Respiratory Diseases, Med. Inflamm., 2016, 1, 10.1155/2016/5628404 · DOI
- Masyuk, 2013, Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases, J. Hepatol., 59, 621, 10.1016/j.jhep.2013.03.028 · DOI · Paper page
- Zhang, 2016, Extracellular vesicles in diagnosis and therapy of kidney diseases, Am. J. Physiol. Renal Physiol., 311, F844, 10.1152/ajprenal.00429.2016 · DOI · Paper page
- Katakowski, 2013, Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth, Cancer Lett., 335, 201, 10.1016/j.canlet.2013.02.019 · DOI · Paper page
- Mendt, 2018, Generation and testing of clinical-grade exosomes for pancreatic cancer, JCI Insight, 3, e99263, 10.1172/jci.insight.99263 · DOI · Paper page
- Shi, 2014, Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes, Proc. Natl. Acad. Sci. USA, 111, 10131, 10.1073/pnas.1409861111 · DOI · Paper page
- Malhotra, 2019, Red Blood Cells-Derived Vesicles for Delivery of Lipophilic Drug Camptothecin, ACS Appl. Mater. Interfaces, 11, 22141, 10.1021/acsami.9b04827 · DOI
- Chang, 2010, Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells, Nanotechnology, 21, 235103, 10.1088/0957-4484/21/23/235103 · DOI
- Gangadaran, 2018, In vivo Non-invasive Imaging of Radio-Labeled Exosome-Mimetics Derived from Red Blood Cells in Mice, Front. Pharmacol., 9, 817, 10.3389/fphar.2018.00817 · DOI
- Iwamoto, 2013, Clinical Application of Drug Delivery Systems in Cancer Chemotherapy: Review of the Efficacy and Side Effects of Approved Drugs, Biol. Pharm. Bull., 36, 715, 10.1248/bpb.b12-01102 · DOI · Paper page
- Veronese, 2005, PEGylation, successful approach to drug delivery, Drug Discov. Today, 10, 1451, 10.1016/S1359-6446(05)03575-0 · DOI · Paper page
- Ihler, 1973, Enzyme Loading of Erythrocytes, Proc. Natl. Acad. Sci. USA, 70, 2663, 10.1073/pnas.70.9.2663 · DOI · Paper page
- Serafini, 2008, Cell-based drug delivery, Adv. Drug Deliv. Rev., 60, 286, 10.1016/j.addr.2007.08.029 · DOI · Paper page
- Hamidi, 2003, Carrier Erythrocytes: An Overview, Drug Deliv., 10, 9, 10.1080/713840329 · DOI · Paper page
- Dehaini, 2017, Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization, Adv. Mater., 29, 1606209, 10.1002/adma.201606209 · DOI · Paper page
- Yoo, 2011, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nat. Rev. Drug Discov., 10, 521, 10.1038/nrd3499 · DOI · Paper page
- Doshi, 2009, Red blood cell-mimicking synthetic biomaterial particles, Proc. Natl. Acad. Sci. USA, 106, 21495, 10.1073/pnas.0907127106 · DOI · Paper page
- Tsai, 2010, Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels, Blood Cells Mol. Dis., 45, 67, 10.1016/j.bcmd.2010.02.016 · DOI · Paper page
- Rauterberg, 1986, Homologous species restriction in lysis of human erythrocytes: A membrane-derived protein with C8-binding capacity functions as an inhibitor, J. Immunol., 136, 1772, 10.4049/jimmunol.136.5.1772 · doi:10.4049/jimmunol.136.5.1772
- Zalman, 1986, Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels, Proc. Natl. Acad. Sci. USA, 83, 6975, 10.1073/pnas.83.18.6975 · doi:10.1073/pnas.83.18.6975
- Kim, 2008, Deficiency of decay-accelerating factor and complement receptor 1–related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg, Blood, 112, 1109, 10.1182/blood-2008-01-134304 · DOI
- Fang, 2012, Nanoparticles disguised as red blood cells to evade the immune system, Expert Opin. Biol. Therapy, 12, 385, 10.1517/14712598.2012.661710 · DOI · Paper page
- Hu, 2011, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform, Proc. Natl. Acad. Sci. USA, 108, 10980, 10.1073/pnas.1106634108 · DOI · Paper page
- Tajerzadeh, 2000, Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes, Drug Dev. Ind. Pharm., 26, 1247, 10.1081/DDC-100102306 · doi:10.1081/ddc-100102306
- Lynch, 2011, pH-responsive polymers for trehalose loading and desiccation protection of human red blood cells, Biomaterials, 32, 4443, 10.1016/j.biomaterials.2011.02.062 · DOI
- Ren, 2016, Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy, Biomaterials, 92, 13, 10.1016/j.biomaterials.2016.03.026 · DOI · Paper page
- Luk, 2014, Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles, Nanoscale, 6, 2730, 10.1039/C3NR06371B · DOI · Paper page
- Xia, 2019, Red blood cell membrane-camouflaged nanoparticles: A novel drug delivery system for antitumor application, Acta Pharm. Sin. B, 9, 675, 10.1016/j.apsb.2019.01.011 · DOI · Paper page
- Miyazaki, 1998, Gene Transfer into Muscle by Electroporation In Vivo, Gene Therapy Protocols, 69, 49, 10.1385/1-59259-141-8:049 · DOI · Paper page
- Zhang, 2015, Synthesis of Nanogels via Cell Membrane-Templated Polymerization, Small, 11, 4309, 10.1002/smll.201500987 · DOI
- Su, 2016, Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer, Adv. Funct. Mater., 26, 1243, 10.1002/adfm.201504780 · DOI · Paper page
- Martinive, 2006, Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery, Mol. Cancer Ther., 5, 1620, 10.1158/1535-7163.MCT-05-0472 · DOI
- Sonveaux, 2004, Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: Implications for cancer treatment, Cancer Res., 64, 3209, 10.1158/0008-5472.CAN-03-1291 · DOI · Paper page
- Hamid, 2018, Preparation and optimization of surface-engineered poly(lactic acid) microspheres as a drug delivery device, J. Mater. Sci., 53, 4745, 10.1007/s10853-017-1840-9 · DOI
- McCall, 2013, PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS, J. Visualized Exp., 82, 51015
- Fang, 2014, Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery, Nano Lett., 14, 2181, 10.1021/nl500618u · DOI · Paper page
- Lin, 2013, The preparation and characteristic of poly(lactide co-glycolide) microspheres as novel antigen delivery systems, Int. J. Nanotechnol., 10, 870, 10.1504/IJNT.2013.058116 · DOI
- Xing, 2016, Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer, Theranostics, 6, 1573, 10.7150/thno.15164 · DOI
- Hao, R., Xing, R., Xu, Z., Hou, Y., Gao, S., and Sun, S. (2010). ChemInform Abstract: Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Chem. Inform., 41. · DOI
- Sharifi, 2015, Superparamagnetic iron oxide nanoparticles forin vivomolecular and cellular imaging, Contrast Med. Mol. Imaging, 10, 329, 10.1002/cmmi.1638 · DOI
200 of 216 shown
Cited by
Different sourced extracellular vesicles and their potential applications in clinical treatments
Bahmani, L., & Ullah, M. (2022) · Cells · doi:10.3390/cells11131989 · Cited by 83
Extracellular vesicles and lipoproteins – Smart messengers of blood cells in the circulation
Nguyen, P. H. D., Le, A. H., Pek, J. S. Q., Pham, T. T., Jayasinghe, M. K., Do, D. V., Phung, C. D., & Le, M. T. N. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.49 · Cited by 31
Metadata
- Authors
- Thangaraju, K., Neerukonda, S. N., Katneni, U., & Buehler, P. W.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-25
- Volume
- 22
- Issue
- 1
- Pages
- 153
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3113596901
- Cited by
- 164
- References
- 24
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.